newsfilter
← Latest News
GlobeNewswire·

Vaccinex, Inc. to Present at the 2023 AAIC Advancements: Immunity Conference

ROCHESTER, N.Y., March 23, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (NASDAQ:VCNX, "Vaccinex")), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and